| Stephen Michael Quillen, PHARMD, PA-C | |
|
17273 State Route 104, Chillicothe, OH 45601-9718 | |
| (740) 773-1141 | |
| Not Available |
| Full Name | Stephen Michael Quillen |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 17273 State Route 104, Chillicothe, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205184520 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 003674 (Ohio) | Secondary |
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 03132330 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Michael Quillen, PHARMD, PA-C 17273 State Route 104, Building 31 Room 1-209, Chillicothe, OH 45601-9718 Ph: (740) 773-1141 | Stephen Michael Quillen, PHARMD, PA-C 17273 State Route 104, Chillicothe, OH 45601-9718 Ph: (740) 773-1141 |
News Archive
On Friday, the Food and Drug Administration (FDA) convened a panel of experts to review recent findings that rotavirus vaccines given to infants in the U.S., Rotateq, produced by Merck Pharmaceuticals and Rotarix produced by GlaxoSmithKline, are contaminated with DNA from pig viruses PCV1 and PCV2. On March 22nd the FDA Commissioner asked doctors to suspend use of the Rotarix vaccine due to the contamination. Upon additional testing, Rotateq was also found to be contaminated.
A study has found that, if left unchecked, 43 percent of Americans will be obese by 2018, costing the health care system $344 billion annually.
There is a great deal of interest in factors that contribute to the vulnerability to developing post-traumatic stress disorder, or PTSD. One factor that appears to contribute to the heritable vulnerability to PTSD is a variation in the gene that codes for the serotonin transporter, also known as the serotonin uptake site. Having a shorter version of the serotonin transporter gene appears to increase one's risk for depression and PTSD after exposure to extremely stressful situations.
Researchers have used positron emission tomography to successfully identify genetic cell mutations that can cause lung cancer.
SynGen, Inc., a company that focuses on the development and commercialization of instrument systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and cell culture, announced today that it has secured additional financing from Bay City Capital, LLC, a San Francisco-based life sciences venture capital firm.
› Verified 7 days ago